PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmbBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Molecular Biology
 
BMC Mol Biol. 2012; 13: 12.
Published online 2012 March 26. doi:  10.1186/1471-2199-13-12
PMCID: PMC3324385
High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
Inge Søkilde Pedersen,corresponding author1 Henrik Bygum Krarup,1 Ole Thorlacius-Ussing,2 and Poul Henning Madsen1
1Section of Molecular Diagnostics, Department of Clinical Biochemistry, Aalborg University Hospital, Denmark, DK
2Department of Surgical Gastroenterology, Aalborg University Hospital, Denmark, DK
corresponding authorCorresponding author.
Inge Søkilde Pedersen: isp/at/rn.dk; Henrik Bygum Krarup: h.krarup/at/rn.dk; Ole Thorlacius-Ussing: otu/at/rn.dk; Poul Henning Madsen: phm/at/rn.dk
Received November 17, 2011; Accepted March 26, 2012.
Abstract
Background
Detection of cell-free methylated DNA in plasma is a promising tool for tumour diagnosis and monitoring. Due to the very low amounts of cell-free DNA in plasma, analytical sensitivity is of utmost importance. The vast majority of currently available methods for analysing DNA methylation are based on bisulfite-mediated deamination of cytosine. Cytosine is rapidly converted to uracil during bisulfite treatment, whereas 5-methylcytosine is only slowly converted. Hence, bisulfite treatment converts an epigenetic modification into a difference in sequence, amenable to analysis either by sequencing or PCR based methods. However, the recovery of bisulfite-converted DNA is very poor.
Results
Here we introduce an alternative method for the crucial steps of bisulfite treatment with high recovery. The method is based on an accelerated deamination step and alkaline desulfonation in combination with magnetic silica purification of DNA, allowing preparation of deaminated DNA from patient samples in less than 2 hours.
Conclusions
The method presented here allows low levels of DNA to be easily and reliably analysed, a prerequisite for the clinical usefulness of cell-free methylated DNA detection in plasma.
Articles from BMC Molecular Biology are provided here courtesy of
BioMed Central